Ch12 1 ClassExamples
Ch12 1 ClassExamples
Organizational costs are expensed as incurred. Since they are not capitalized, they are not amortized.
Examples 1, 2 and 3
The impairment loss is the difference between carrying value (book value) and fair value
Examples 4 and 5
e are expensed as incurred.
ot amortized.
Patent 54,000
Cash 54,000
Cost 54,000
Less: Accumulated Depreciation 5,400
Carrying Value 48,600
Assume that in January of 2022, when the carrying value of Merck’s patent is $43,200, Merck
spends $24,000 successfully defending the patent in court. Merck estimates the patent will be
useful until the end of 2029.
Record Merck’s entry on in January 2022 for legal costs of defending the patent.
Patent 24,000
Cash 24,000
What is the amount of amortization expense that will be recorded at the end of the year?
Record Merck’s entry for amortization expense for the year ended 12/31/22.
8 years remaining
Assume that Big Tech Company incurred the following costs this period:
· When the company begain on Jan. 1, 2020, it incurred $60,000 of costs due to fees to underwriters, legal fees,
expenditures during its formation.
· Purchased a license for $20,000 on Jan. 1, 2020. The license gives the company exclusive rights to sell its ser
expire at the end of ten years.
· Purchased a patent on Jan. 2, 2020 for $40,000. It is estimated to have a 5-year useful life and has a legal life
· Costs incurred on Jan. 2, 2020 to develop an exclusive internet connection process totaled $45,000.
You are preparing the year-end 12/31/20 balance sheet and income statement and need to answer the following qu
What will the year-ened 2020 income statement and balance sheet report related to the organization costs?
The income statement will report $60,000 organization costs for 2020
The balance sheet will not report anything related to the organizational costs
What will the year-ened 2020 income statement and balance sheet report related to the license?
The income statement will report Amortization Expense of $2,000 (20,000 /10)
What will the year-ened 2020 income statement and balance sheet report related to the patent?
The income statement will report Amortization Expense of $8,000 (40,000 /5)
What will the year-ened 2020 income statement and balance sheet report related to the costs of developing
The income statement will report Research and Development Expense of $45,000
The balance sheet will not report anything related to the cost of developing the new process.
What is the amount of total Intangible Assets that will be reported on the 12/31/20 balance sheet?
License 18,000
Patent 32,000
Total 50,000
es to underwriters, legal fees, and promotional
to the license?
to the patent?
0 balance sheet?
Assume that Darden Restaurants purchases a franchise from McDonald’s for $120,000 on
April 1, 2020. The franchise grants Darden Restaurants the right to sell certain products for a
period of 8 years.
Franchise 120,000
Cash 120,000
At what amount would the franchise be reported on Darden Restaurant’s 12/31/20 balance sheet?
Cost 120,000
Less: Accumulated Amortization 11,250
Carrying Value 108,750
Would either of the entries recorded above change if the franchise was expected to have an
indefinite useful life instead of 8 years?
The first entry for the purchase of the franchise would stay the same
However, there is no entry for Amortization Expense if the franchise has an indefinite useful life.
/ 8 years) x (9/12 months)
ted to have an
te useful life.
Lerch, Inc. has a patent on how to extract oil from shale rock. Unfortunately, several recent non-shale oil discoveries
the demand for shale-oil technology. As a result, Lerch performs a recoverability test. It finds that the expected futur
this patent are $35 million. Lerch’s patent has a carrying amount of $60 million. Discounting the expected future net
market rate of interest, Lerch determines the fair value of its patent to be $20 million.
Determine whether the patent is impaired and if so, record the journal entry for the impairment.
Recoverability test:
Carrying value of 60,000,000 is greater than the expected future cash flows of 35,000,000. Impairment is needed.
What amount will the balance sheet report related to the Patent?
Patent 20,000,000 After impairment is recorded, the carying value will equal fair value
t non-shale oil discoveries adversely affected
ds that the expected future net cash flows from
g the expected future net cash flows at its
mpairment.
Impairment is needed.
Assume that Moderna purchased a patent from NuDrug Company for $1,000,000 on Jan. 1, 2020.
The patent is being amortized over its remaining legal life of 10 years.
On Jan. 1, 2021, legal costs of $200,000 were incurred to successfully defend the patent.
Calculate amortization for 2020, the 12/31/20 book value, 2021 amortization, and 12/31/21 book value.
At the beginning of 2022, Moderna determines the following information related to the patent:
Fair value 500,000
Expected future cash flows 680,000
Calculate amortization expense for 2022 and the 12/31/22 book value.
to the patent:
flows of 680,000
Multiple Choice Practice Questions
Question 1
Which of the following does not describe intangible assets?
a) They lack physical existence.
b) They are financial instruments.
c) They provide long-term benefits.
d) They are classified as long-term assets.
Question 2
Assume that Pfizer incurred $80,000 of costs on April 1, 2020, related to researching
a new drug to prevent COVID-19. How should this cost be accounted for?
a) An expense on the income statement
b) An intangible asset on the balance sheet.
c) Some of the cost is an intangible asset on the balance sheet and the some of the
cost is an expense on the income statement.
Question 3
When the journal entry for amortization expense is recorded:
a) assets decrease
b) liabilities increase
c) net income increases
d) none of the above are correct
Question 4
For each of the following items, determine whether the cost should be capitalized or expensed:
1. Cost of engineering activity required in the design of a new product.
2. The legal cost incurred in successfully defending a copyright.
3. Cost of developing a patent.
4. Cost of purchasing a trademark.
d or expensed: